Home > Result Summaries: Compounds > GSK249320 Result Summaries: GSK249320 GSKStudy ID Phase Title Summary (Download) 111539 phase 2 A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke (0 citation(s)) MAG103114 phase 1 A single-blind, single dose, placebo controlled, parallel group, first time in human study to assess the safety, tolerability, pharmacokinetics and immunogenicity of ascending IV doses of GSK249320 in healthy volunteers (0 citation(s))
